Insider Transactions in Q3 2022 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2022
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,600,000
+16.03%
|
-
|
|
Sep 26
2022
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,600,000
+16.73%
|
-
|
|
Sep 26
2022
|
Claire Poll General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+23.79%
|
-
|
|
Sep 26
2022
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+20.12%
|
-
|
|
Aug 21
2022
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
90,104
+9.64%
|
-
|
|
Aug 21
2022
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
90,104
-3.93%
|
-
|
|
Aug 15
2022
|
Access Industries Holdings LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,800,000
+7.91%
|
$4,800,000
$1.31 P/Share
|
|
Aug 09
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.78%
|
$600,000
$1.75 P/Share
|
|
Aug 09
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-4.02%
|
$600,000
$1.75 P/Share
|
|
Aug 02
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,752
-1.2%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
32,904
-0.21%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
454,864
-2.78%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,432
-2.29%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Claire Poll General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
79,896
-4.34%
|
$0
$0.67 P/Share
|
|
Aug 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,168
-0.09%
|
$0
$0.7 P/Share
|
|
Aug 01
2022
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
454,856
-2.96%
|
$0
$0.67 P/Share
|